BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35059891)

  • 1. A possible case of carbamazepine-induced renal phospholipidosis mimicking Fabry disease.
    Chen J; Bai L; He Y
    Clin Exp Nephrol; 2022 Mar; 26(3):303-304. PubMed ID: 35059891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural deposits appearing as "zebra bodies" in renal biopsy: Fabry disease?- comparative case reports.
    de Menezes Neves PDM; Machado JR; Custódio FB; Dos Reis Monteiro MLG; Iwamoto S; Freire M; Ferreira MF; Dos Reis MA
    BMC Nephrol; 2017 May; 18(1):157. PubMed ID: 28499424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden onset of nephrotic syndrome in an asymptomatic Fabry patient: a case report.
    Zhang R; Chen Z; Lang Y; Shao S; Cai Y; You Q; Sun Y; Wang S; Shi X; Liu Z; Guo W; Han Y; Shao L
    Ren Fail; 2020 Nov; 42(1):958-965. PubMed ID: 32924720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid bodies is not an uncommon ultrastructural finding.
    Choung HYG; Jean-Gilles J; Goldman B
    Ultrastruct Pathol; 2022 Jan; 46(1):130-138. PubMed ID: 35100945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic renal failure and proteinuria in adulthood: Fabry disease predominantly affecting the kidneys.
    Cybulla M; Schaefer E; Wendt S; Ling H; Kröber SM; Hövelborn U; Schandelmaier S; Rohrbach R; Neumann HP
    Am J Kidney Dis; 2005 May; 45(5):e82-9. PubMed ID: 15861341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coincidence of IgA nephropathy and Fabry disease.
    Maixnerová D; Tesař V; Ryšavá R; Reiterová J; Poupětová H; Dvořáková L; Goláň L; Neprašová M; Kidorová J; Merta M; Honsová E
    BMC Nephrol; 2013 Jan; 14():6. PubMed ID: 23305247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.
    Takahashi N; Yokoi S; Kasuno K; Kogami A; Tsukimura T; Togawa T; Saito S; Ohno K; Hara M; Kurosawa H; Hirayama Y; Kurose T; Yokoyama Y; Mikami D; Kimura H; Naiki H; Sakuraba H; Iwano M
    Clin Nephrol; 2015 May; 83(5):301-8. PubMed ID: 25295576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of female Fabry disease revealed by renal biopsy.
    Aratani S; Yamakawa H; Suzuki S; Otsuka T; Sakai Y; Shimizu A; Tsuruoka S
    CEN Case Rep; 2020 Feb; 9(1):24-29. PubMed ID: 31542871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α-galactosidase A activity: A 14-year follow-up without enzyme replacement therapy.
    Odani K; Okumi M; Honda K; Ishida H; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():57-9. PubMed ID: 26971403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine-induced renal phospholipidosis resembling Fabry disease in undifferentiated connective tissue disease: A case report.
    Wu SZ; Liang X; Geng J; Zhang MB; Xie N; Su XY
    World J Clin Cases; 2019 Dec; 7(24):4377-4383. PubMed ID: 31911921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo mutation in a male patient with Fabry disease: a case report.
    Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
    BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial screening of Fabry disease in patients with hypohidrosis.
    Nagai-Sangawa M; Fukunaga A; Takeuchi C; Nishiyama S; Horikawa T; Nagano C; Nozu K; Fujii H; Nishigori C
    J Dermatol; 2022 Feb; 49(2):308-312. PubMed ID: 34796992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teenager male with burning pain in extremities--suspect Fabry disease, 2 case reports.
    Patil RB; Joglekar VK
    J Assoc Physicians India; 2014 Jan; 62(1):69-71. PubMed ID: 25327101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia.
    Mallett A; Kearey P; Cameron A; Healy H; Denaro C; Thomas M; Lee VW; Stark S; Fuller M; Hoy WE
    BMC Nephrol; 2020 Feb; 21(1):58. PubMed ID: 32087678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review.
    Fujisawa H; Nakayama Y; Nakao S; Yamamoto R; Kurokawa Y; Nakamura N; Nagata A; Tsukimura T; Togawa T; Sakuraba H; Fukami K
    BMC Nephrol; 2019 Dec; 20(1):469. PubMed ID: 31847900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First phenotypic description of a female patient with c.610 T > C variant of GLA: a renal-predominant presentation of Fabry disease.
    Greillier S; Daniel L; Caillaud C; Dussol B; Touchard G; Goujon JM; Jourde-Chiche N; Bobot M
    BMC Med Genet; 2020 Jun; 21(1):137. PubMed ID: 32590976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal involvement in Fabry disease.
    Abensur H; Reis MA
    J Bras Nefrol; 2016 Jun; 38(2):245-54. PubMed ID: 27438980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications.
    Meehan SM; Junsanto T; Rydel JJ; Desnick RJ
    Am J Kidney Dis; 2004 Jan; 43(1):164-71. PubMed ID: 14712441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry Nephropathy: An Evidence-Based Narrative Review.
    Del Pino M; Andrés A; Bernabéu AÁ; de Juan-Rivera J; Fernández E; de Dios García Díaz J; Hernández D; Luño J; Fernández IM; Paniagua J; Posada de la Paz M; Rodríguez-Pérez JC; Santamaría R; Torra R; Ambros JT; Vidau P; Torregrosa JV
    Kidney Blood Press Res; 2018; 43(2):406-421. PubMed ID: 29558749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis.
    van der Tol L; Svarstad E; Ortiz A; Tøndel C; Oliveira JP; Vogt L; Waldek S; Hughes DA; Lachmann RH; Terryn W; Hollak CE; Florquin S; van den Bergh Weerman MA; Wanner C; West ML; Biegstraaten M; Linthorst GE
    Mol Genet Metab; 2015 Feb; 114(2):242-7. PubMed ID: 25187469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.